The three terms, distinguished
The vocabulary is genuinely confusing because the words were coined at different times by different fields, and marketing has since blurred them further. The distinction is actually simple.
- Probiotics — live microorganisms intended to confer a benefit when consumed in adequate amounts. Yoghurt cultures, multi-strain capsules, kefir.
- Prebiotics — substrates that feed beneficial organisms already present. Typically fibres: inulin, resistant starch, galacto-oligosaccharides.
- Postbiotics — the compounds produced by microorganisms during fermentation, delivered without the organisms. Metabolites, peptides, cell-wall fractions, enzymes.
Why the format matters
A probiotic has a delivery problem that is rarely stated plainly on the label. The organisms must survive manufacturing, survive the shelf, survive stomach acid, arrive in the intestine viable, and then establish themselves against an incumbent population that is already there and not especially welcoming.
Each of those is a loss point, and the losses are why live-culture products carry refrigeration requirements, colony-forming-unit counts that decline measurably across shelf life, and famously variable individual results.
A postbiotic has no delivery chain to fail. The useful molecules were produced under controlled conditions, separated, and stabilised. Nothing has to survive anything. The dose stated on the bottle is the dose that arrives.
Postbiotics are not automatically better
This is where we differ from most of the category, which treats "postbiotic" as a straightforward upgrade. It is not. It is a different tool for a different job.
If your goal is rebuilding gut flora after a course of antibiotics, you want live organisms, because repopulating requires something alive to do the repopulating. No postbiotic accomplishes that, and any brand implying otherwise is selling past the evidence.
Where postbiotics are genuinely advantageous is anywhere the target is a specific compound rather than a resident population — and anywhere reliability over a long protocol matters more than colonisation.
Fermentation-derived compounds are not new
Nothing about the underlying idea is novel, which is a point in its favour rather than against. Human food cultures have relied on fermentation-derived compounds for millennia — miso, natto, koji, aged cheeses, sourdough, soy sauce. In each case what is valued is substantially what the organisms produced, not the organisms themselves.
What is new is the isolation and characterisation: identifying a specific metabolite fraction, documenting it, and delivering it at a consistent dose. That is a manufacturing and analytical advance rather than a conceptual one.
Where Bacillus F fits
Our product is a postbiotic in the strict sense: the metabolite fraction of the Bacillus F strain, produced under controlled fermentation, separated from the cells, cold-processed into drops. There are no live organisms in the bottle and we state that on every page rather than leaving it to be inferred.
The practical profile follows directly from the format — room-temperature storage, no viability decline, chemically consistent batch to batch, and identical potency at day ninety. For a daily habit meant to run for months, that reliability is usually what determines whether the habit survives at all.
If what you actually needed was a live culture, we would rather tell you that here than take the sale.